Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Libby's H*O*P*E*

Libby's H*O*P*E*

Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education). To learn more go to
New general concept for the treatment of cancer - Karolinska Institutet -
2014 AACR: Fox Chase Cancer Center : Scaffolding Protein Promotes Growth and Metastases of Epithelial Ovarian Cancer -
Zombie Cancer Cells Eat Themselves to Live - Colorado Cancer Blogs -
Jamming a protein signal forces cancer cells to devour themselves | MD Anderson Cancer Center -
Removal of ovaries cuts risk of cancer death by 80% for those with gene mutation, study finds - The Globe and Mail -
Preventive ovary removal for BRCA carriers reduces mortality - ONA -
Ambry Genetics Launches A New Generation of Clinical Exome Sequencing | Ambry Genetics -
International Consortium Discovers Two Genes that Modulate Risk of Breast and Ovarian Cancer -
American Association of Cancer Researchers (AACR) Annual Meeting Online Proceedings (Abstracts) and Itinerary Planner -
2014 AACR: Rexahn Pharmaceuticals to Present Data on RX-3117 ( small molecule cytidine analog) and RX-21101(polymer conjugated form of docetaxel)... |
2014 AACR: Senhwa Biosciences Announces CX-5461 Research Study Findings re Identification of PI3K Pathway Combinations & MYC Driven Cancers -
2014 AACR: Celldex Therapeutics to Present Antibody-Drug Conjugate CDX-014 Preclinical Proof of Concept Data ... -
2014 AACR: Champions Oncology to Present Posters on Personalized Medicine TumorGraft Application in Clinical and Research Settingsl... -
2014 AACR: Bayer to present clinical phase 1 results in patients w/advanced stage small cell lung or ovarian cancer using oral pan-CDK inihibitor Roniciclib (BAY 1000394). -
2014 AACR: Novocure to Present New Pre-Clinical Data on NovoTTF™ Therapy at the American Association for Cancer Research Annual Meeting 2014 | SYS-CON MEDIA -
2014 AACR: Immunovaccine to Present Data on Cancer Vaccine Combination Therapies at the 2014 AACR Annual Meeting - MarketWatch -
Combining with cyclophosphamide and the checkpoint inhibitor anti-PD-1 enhances the therapeutic potential of vaccine. - Libby's H*O*P*E*
2014 AACR: Data for Endocyte's Folate Receptor (FR)-Targeting Folate-Tubulysin Conjugate, EC1456, and Prostate-Specific Membrane Antigen (PSMA)-Targeted Tubulysin, SMDC, EC1169, to be Presented-
2014 AACR: Screening Reveals Additional Link Between Endometriosis and Ovarian Cancer -
2014 AACR: Disease-Free Survival Estimates for Ovarian Cancer Improve Over Time -
Ginger May Be an Answer for Prostate and Ovarian Cancer -
Targeted treatment of ovarian cancer - the multiple - kinase - inhibitor sorafenib as a potential option.... [Anticancer Res. 2014] - PubMed - NCBI -
Ovarian Cancer Animated Short - YouTube -
Is There a Link Between Endometriosis and Ovarian Cancer? -
Cancer researchers find key protein link -
Even Top Docs Admit: Unready for Cancer Gene Testing -
Does cancer risk increase with HbA1c, independent of diabetes|[quest]| : British Journal of Cancer -
Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom : British Journal of Cancer -
2014 SGO: Debulking, IP Chemo Best for Ovarian Ca -
Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT® (vintafolide) and Companion Imaging Agents FOLCEPRI® (etarfolatide) and NEOCEPRI® (Intravenous (IV) folic acid)in Patients with Platinum-Resistant ... - MarketWatch -...
2014 SGO: Anti-PARP Tx Works in Advanced Ovarian Cancer -
Other ways to read this feed:Feed readerFacebook